Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia

Cancer-associated isocitrate dehydrogenase (IDH) mutations produce the metabolite 2-hydroxyglutarate (2HG), but the clinical utility of 2HG has not been established. We studied whether 2HG measurements in acute myeloid leukemia (AML) patients correlate with IDH mutations, and whether diagnostic or r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: DiNardo, Courtney D., Propert, Kathleen J., Loren, Alison W., Paietta, Elisabeth, Sun, Zhuoxin, Levine, Ross L., Straley, Kimberly S., Yen, Katharine, Patel, Jay P., Agresta, Samuel, Abdel-Wahab, Omar, Perl, Alexander E., Litzow, Mark R., Rowe, Jacob M., Lazarus, Hillard M., Fernandez, Hugo F., Margolis, David J., Tallman, Martin S., Luger, Selina M., Carroll, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2013
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682342/
https://ncbi.nlm.nih.gov/pubmed/23641016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-493197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados